102 related articles for article (PubMed ID: 37921060)
1. MEK/ERK and PI3K/AKT pathway inhibitors affect the transformation of myelodysplastic syndrome into acute myeloid leukemia via H3K27me3 methylases and de‑methylases.
Zheng Z; Chen X; Zhang Y; Ren F; Ma Y
Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37921060
[TBL] [Abstract][Full Text] [Related]
2. Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia.
Roversi FM; Bueno MLP; da Silva JAF; Assis-Mendonça GR; Torello CO; Shiraishi RN; Pericole FV; Ferro KP; Duarte ASS; Rego EM; Saad STO
Cancer Immunol Immunother; 2022 Aug; 71(8):1909-1921. PubMed ID: 35039904
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells.
Şansaçar M; Sağır H; Gencer Akçok EB
Med Oncol; 2023 Dec; 41(1):31. PubMed ID: 38148433
[TBL] [Abstract][Full Text] [Related]
4. Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy.
Hu T; Zhou R; Zhao Y; Wu G
Sci Rep; 2016 Sep; 6():33376. PubMed ID: 27624978
[TBL] [Abstract][Full Text] [Related]
5. Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice.
Polo ML; Arnoni MV; Riggio M; Wargon V; Lanari C; Novaro V
PLoS One; 2010 May; 5(5):e10786. PubMed ID: 20520761
[TBL] [Abstract][Full Text] [Related]
6. Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis.
Tseng CY; Fu YH; Ou DL; Lu JW; Hou HA; Lin LI
Cancer Gene Ther; 2023 Dec; 30(12):1691-1701. PubMed ID: 37821641
[TBL] [Abstract][Full Text] [Related]
7. UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation.
Wang L; Zhao S; Wang Y; Liu J; Wang X
BMC Cancer; 2024 Apr; 24(1):497. PubMed ID: 38637730
[TBL] [Abstract][Full Text] [Related]
8. Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium.
Sánchez-Ceinos J; Hussain S; Khan AW; Zhang L; Almahmeed W; Pernow J; Cosentino F
Cardiovasc Diabetol; 2024 Apr; 23(1):122. PubMed ID: 38580969
[TBL] [Abstract][Full Text] [Related]
9. MAPK/ERK and PI3K/AKT signaling pathways are activated in adolescent and adult acute lymphoblastic leukemia.
Loureiro G; Bahia DM; Lee MLM; de Souza MP; Kimura EYS; Rezende DC; Silva MCA; Chauffaille MLLF; Yamamoto M
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1912. PubMed ID: 37867416
[TBL] [Abstract][Full Text] [Related]
10. PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells.
Ames K; Kaur I; Shi Y; Tong MM; Sinclair T; Hemmati S; Glushakow-Smith SG; Tein E; Gurska L; Steidl U; Dubin R; Shan J; Montagna C; Pradhan K; Verma A; Gritsman K
Sci Adv; 2023 Feb; 9(8):eade8222. PubMed ID: 36812307
[TBL] [Abstract][Full Text] [Related]
11. Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy.
Zhou Q; Zhang J; Zhang J; Liang S; Cai D; Xiao H; Zhu Y; Xiang W; Rodrigues-Lima F; Chi J; Guidez F; Wang L
Biol Direct; 2024 Jan; 19(1):6. PubMed ID: 38178263
[TBL] [Abstract][Full Text] [Related]
12. Twist1 Promoter Methylation Regulates the Proliferation and Apoptosis of Acute Myeloid Leukemia Cells via PI3K/AKT Pathway.
Gong A; Wang X; Wang X; Zhao Y; Cui Y
Indian J Hematol Blood Transfus; 2023 Jan; 39(1):25-32. PubMed ID: 36699440
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid Leukemia.
Fobare S; Elgamal OA; Wunderlich M; Stahl E; Mehmood A; Furby C; Lerma JR; Sesterhenn TM; Pan J; Rai J; Johnstone ME; Abdul-Aziz A; Johnson ML; Rai SN; Byrd JC; Hertlein E
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339323
[TBL] [Abstract][Full Text] [Related]
14. IRAK1: oncotarget in MDS and AML.
Beverly LJ; Starczynowski DT
Oncotarget; 2014 Apr; 5(7):1699-700. PubMed ID: 24880611
[No Abstract] [Full Text] [Related]
15. FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia.
Dobish KK; Wittorf KJ; Swenson SA; Bean DC; Gavile CM; Woods NT; Ghosal G; Hyde RK; Buckley SM
Leukemia; 2023 Nov; 37(11):2197-2208. PubMed ID: 37689825
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the Link between Class 1A PI3-Kinase, Autophagy, and Myelodysplasia.
Ames K; Gritsman K
Autophagy; 2024 Apr; 20(4):952-954. PubMed ID: 37289024
[TBL] [Abstract][Full Text] [Related]
17. Calothrixin B derivatives induce apoptosis and cell cycle arrest on HEL cells through the ERK/Ras/Raf/MEK pathway.
Wang B; Wang M; Li K; Wang C; Liu X; Rao Q; Song J; Hang Y; Liu S; Wen M; Huang L; Li Y
Biomed Pharmacother; 2024 Feb; 171():116179. PubMed ID: 38278023
[TBL] [Abstract][Full Text] [Related]
18. The Role of H3K27me3-Mediated Th17 Differentiation in Ankylosing Spondylitis.
Chen Y; Liu W; Xu X; Zhen H; Pang B; Zhao Z; Zhao Y; Liu H
Inflammation; 2024 Mar; ():. PubMed ID: 38517649
[TBL] [Abstract][Full Text] [Related]
19. Thymocyte selection-associated high mobility box protein regulates T lymphocytes exhaustion in patients with myelodysplastic syndromes by inhibiting PI3K/AKT/mTOR pathway.
Niu H; Zhang M; Liu M; Yang L; Yang L; Ren J; Yu Y; Liu Y; Xing L; Shao Z; Wang H
Hematol Oncol; 2024 Jan; 42(1):e3224. PubMed ID: 37712442
[TBL] [Abstract][Full Text] [Related]
20. Trichosanthin-derived peptide Tk-PQ attenuates immune rejection in mouse tracheal allotransplant model by suppressing PI3K-Akt and inducing type II immune polarization.
Zhou L; Hou Y; Pan X; Wang X; Jin H; Yang X; Wang K; Ding X; Wang K; Zhu M; Pan Y; Wang W; Lu L
Int Immunopharmacol; 2023 Dec; 125(Pt A):111081. PubMed ID: 37862724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
